Evidence map›Paper›PMID 36145268›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Characterization of a Lab-Scale Process to Produce Whole IgG Antivenom Covering Scorpion Stings by Genus

Sebastian Estrada-Gomez, Vitelbina Núñez, Leidy Johana Vargas-Muñoz, Carlos A Madrid-Bracamonte, Lina Maria Preciado

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sebastian Estrada-GomezGrupo de Toxinología y Alternativas Terapeuticas, Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia UdeA, Medellin 050010, Colombia.
Vitelbina NúñezGrupo de Toxinología y Alternativas Terapeuticas, Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia UdeA, Medellin 050010, Colombia.ORCID 0000-0002-7956-900X
Leidy Johana Vargas-MuñozGrupo de Toxinología y Alternativas Terapeuticas, Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia UdeA, Medellin 050010, Colombia.ORCID 0000-0003-1332-5106
Carlos A Madrid-BracamonteTech Life Saving (TLS), Tech Innovation Group Company, Medellin 050022, Colombia.
Lina Maria PreciadoGrupo de Toxinología y Alternativas Terapeuticas, Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia UdeA, Medellin 050010, Colombia.
Universidad de Antioquia · CO

Funding

Tech Innovation Gropup Antivenom projectUniversity of Antioquia CIQF-284
6 · The paper itself

Abstract

Scorpion stings are a public health event in Colombia lacking official epidemiological data, and are considered a medical emergency. Despite the two local producers of antivenoms, neither of them is currently manufacturing scorpion antivenoms. We present the characterization of a lab-scale process to produce the first specific scorpion antivenom for Colombia, formulated to cover scorpion stings produced by

Indexed as

antivenomsColombiaIgGLD50scorpionvenoms

Identifiers

PMID36145268
PMCPMC9502926
OpenAlexW4293221352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.